// App-Quantinova.ai

BIOM-39 : P-ERK ASSOCIATION WITH OVERALL SURVIVAL IN RECURRENT GBM PATIENTS TREATED WITH INTRACEREBRAL ADMINISTRATION OF PD-1 AND CTLA-4 BLOCKING ANTIBODIES

Researchers

Presenter

  • Victor Arrieta

Principal Investigators

  • Johnny Duerinck

  • Kirsten B Burdett

  • Wietse Geens

  • Julia Katharina Schwarze

  • Andrew Gould

  • LI Chen

  • Matthew McCord

  • Craig Horbinski

  • Hui Zhang

  • Roger Stupp

  • Bart Neyns

  • Adam M Sonabend

Medical Centers

  • Department of Neurosurgery, UZ Brussel, Jette, Belgium

  • Northwestern University — Neurological Surgery

  • Northwestern University, Chicago, USA

  • Feinberg School of Medicine, Chicago, IL, USA

  • Northwestern University, Feinberg School of Medicine, Chicago, IL

Locations

  • Belgium

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Phospho-ERK

  • Cytotoxic T-lymphocyte-associated protein 4

  • Programmed cell death protein 1

Drug/Treatment

  • Ipilimumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • NCT03233152

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved